Mark D. P. Davis

Calciphylaxis: Natural history, risk factor analysis, and outcome

Roger H. Weenig, Lindsay D. Sewell, Mark D. P. Davis et al. · Journal of the American Academy of Dermatology · 2006 · 519 citations

Natural History, Clinical Epidemiology, Forensic Toxicology +3

Natural History of Erythromelalgia

Mark D. P. Davis, W. Michael O’Fallon, Roy S. Rogers et al. · Archives of Dermatology · 2000 · 248 citations

Livedoid Vasculopathy

Bethany R. Hairston, Mark D. P. Davis, Mark R. Pittelkow et al. · Archives of Dermatology · 2006 · 178 citations

Topical tacrolimus in the treatment of symptomatic oral lichen planus: A series of 13 patients

Todd W. Rozycki, Roy S. Rogers, Mark R. Pittelkow et al. · Journal of the American Academy of Dermatology · 2002 · 149 citations

Topical Tacrolimus, Dermatology

Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo Clinic

David A. Wetter, Mark D. P. Davis · Mayo Clinic Proceedings · 2009 · 110 citations

Inflammation, Rheumatology, Mayo Clinic +14